ARTL News and Press, Artelo Biosciences Inc. From 05/04/21

Kintara Therapeutics Appoints Tamara A. Seymour to Board of Directors PR Newswire SAN DIEGO , May 4, 2021 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid t...

Knoll (KNL) +31% as Herman Miller to buy the company for $1.8B.AnPac Bio-Medical Science (ANPC) +23% as its paid CDA-based test volume surge 130% in Q1.Clean Energy Fuels (CLNE) +21% on signing an agreement with Amazon.Manchester United plc (MANU) +10% on breakaway Super L...

Recently Commenced Patient Enrollment in Phase 1/2 CAReS Study of ART27.13 in the UK Reported Positive Pre-Clinical Data Associated with Artelo’s Proprietary CBD Cocrystal $11.2 Million of Cash and Cash Equivalents and Marketable Securities as of February 28, 2021...

Initial safety data expected from CAReS Study before end of 2021 Targeting multi-billion market with no approved therapies for cancer-related anorexia LA JOLLA, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ) , a ...

Changing drug policies on medicinal and recreational cannabis will lead to increased substitution of ART 27.13 and ART 12.11, reducing future revenue streams. ART 26.12 has very little preclinical data, making it especially risky. The company is years away from potential FDA-appro...

VirTra (VTSI) +56% on Q4 results.Color Star Technology Co., Ltd. (CSCW) +56% as company to develop NFT.Performant Financial Corporation (PFMT) +26%.Monopar Therapeutics (MNPR) +18% on preclinical update of its uPA.Moleculin Biotech (MBRX) +18% on FDA's fast track desi...

Artelo Biosciences, Inc. (ARTL) Q1 Virtual Investor Summit Conference March 23, 2021 01:00 PM ET Company Participants Gregory Gorgas - President & Chief Executive Officer Conference Call Participants Presentation Operator You have joined the meeting as an attendee, and will be muted throu...

Are These Robinhood Penny Stocks On Your Buy Or Sell List Right Now? As we end another week in March, both penny stocks and blue chips remain highly volatile. Overall this month has been quite bullish for many stocks under $5, yet broader markets continue trading sideways. Several facto...

Artelo Biosciences (ARTL) announces that it has been accepted into the first round of the Alderley Park Oncology Development Program, a UK national program designed to offer advice, guidance, and financial support to develop and progress innovative oncology projects.The Alderle...

Detection of elevated FABP5 associated with additional tumor types suggests the target for ART26.12 may be more broadly relevant in cancer therapy Alderley Park Oncology Development Program is a UK program designed to develop and progress innovative oncology projects ...